| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 03/27/2008 | WO2008035157A1 Azetidine derivatives as muscarinic receptor antagonists |
| 03/27/2008 | US20080076917 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof |
| 03/27/2008 | CA2664057A1 Azetidine derivatives as muscarinic receptor antagonists |
| 03/26/2008 | EP1902022A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 03/25/2008 | USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/20/2008 | WO2008033278A1 Heterosubstituted n-thiolated beta-lactam compounds and methods of use |
| 03/20/2008 | WO2008032338A2 Improved process for the preparation of ezetimibe and its intermediates |
| 03/20/2008 | US20080070891 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane |
| 03/20/2008 | US20080070890 Spirocyclic Azetidinone Compounds and Methods of Use Thereof |
| 03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/13/2008 | US20080064676 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
| 03/12/2008 | EP1896410A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/12/2008 | EP1896409A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions |
| 03/12/2008 | EP1896408A1 New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases |
| 03/12/2008 | EP1896407A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia |
| 03/12/2008 | EP1896406A2 The preparation and use of compounds as protease inhibitors |
| 03/12/2008 | EP1896135A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids |
| 03/12/2008 | CN101141959A 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/12/2008 | CN101139306A Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 03/11/2008 | US7342005 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; favourable duration of action; infections |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/06/2008 | WO2008027081A1 Processes for the purification of (3r,4s)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-(4-fluorophenyl)-3-oxopropyl] azetidin-2-one |
| 03/06/2008 | US20080058307 Novel compounds as cannabinoid receptor ligands |
| 03/06/2008 | US20080058306 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitors(s) and treatments for vascular indications |
| 03/06/2008 | US20080058305 Processes for the purification of (3R,4S)-4-(4-hydroxy-protected-phenyl)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one |
| 03/06/2008 | US20080058304 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 03/05/2008 | EP1893571A2 Process for production of 4-biphenylyazetidin-2-ones |
| 03/05/2008 | EP1893570A1 Improved process for the preparation of ezetimibe |
| 03/05/2008 | EP1893222A2 Anti-hypercholesterolemic compounds |
| 03/05/2008 | CN101134739A Novel beta-lactam compound and preparation method and chemical uses thereof |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/28/2008 | WO2008024892A2 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 02/28/2008 | WO2008022945A1 Aryl sulfonamides with an analgesic action |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | CA2663598A1 New compounds |
| 02/28/2008 | CA2661401A1 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 02/27/2008 | CN101133020A Ezetimibe polymorphs |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example |
| 02/21/2008 | WO2008020597A1 Method for producing 1-methylcarbapenem production intermediate |
| 02/21/2008 | US20080045726 Used as ultraviolet radiation absorber; such as 1-aza(3.5)nona(5,8)dione derivative substituted in first position with oxy, thio, carbonyl group |
| 02/21/2008 | US20080045690 Azetidine Derivatives, Method for Producing Said Derivatives and Use Thereof |
| 02/21/2008 | US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide |
| 02/21/2008 | US20080045492 Mitotic Kinesin Inhibitors |
| 02/21/2008 | US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1888522A2 ß-LACTAM SYNTHESIS |
| 02/20/2008 | EP1888521A2 RESOLUTION OF ENANTIOMERIC MIXTURES OF ß-LACTAMS |
| 02/20/2008 | CN101128419A Process for preparing protected amiidines |
| 02/20/2008 | CN100369896C Cyclic amino compounds |
| 02/19/2008 | USRE40086 [4S-(4,12a alpha )]-4-(dimethylamino)-7-(substituted)-9-(substituted amino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12 a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamides; wide spectrum bactericides, including tetracycline-resistant strains; veterinary medicine |
| 02/14/2008 | US20080039635 Method for the Production of a Compound, Comprising a Free Hydroxyl Group and a Hydroxyl Group Which is Protected by an Ester Function by Enzymatic Reaction |
| 02/14/2008 | US20080039438 1B-Methylcarbapenem Derivative and Process for the Preparation Thereof |
| 02/13/2008 | EP1885694A2 4-biarylyl-1-phenylazetidin-2-ones |
| 02/13/2008 | EP1613589B1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter |
| 02/12/2008 | CA2367289C Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(r)-[3(s)-hydroxy-3-(4-fluorophenyl)propyl)]-4(s)-(4-hydroxyphenyl)-2-azetidinone |
| 02/07/2008 | WO2008016007A1 METALLO-β-LACTAMASE INHIBITOR |
| 02/07/2008 | US20080032964 Process for the synthesis of azetidinone |
| 02/06/2008 | CN101119966A Process for the synthesis of azetidinones |
| 02/05/2008 | US7326796 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 01/31/2008 | WO2007122488A3 Radiofluorinated compounds and their preparation |
| 01/31/2008 | WO2007119106A3 Processes for preparing intermediate compounds useful for the preparation of ezetimibe |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/24/2008 | WO2007136326A3 ) t e text as een esta s e y t s ut o ty to rea as o ows: 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 3 |
| 01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
| 01/24/2008 | US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents |
| 01/24/2008 | US20080021010 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction |
| 01/23/2008 | EP1879860A2 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 01/22/2008 | US7320972 Hypercholesterolemia, cholesterol-associated benign and malignant tumors; hyperlipidemia, arteriosclerosis, and sitosterolemia; 6) (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(2',3',4'-trimethoxybiphenyl-4-yl)azetidin-2-one |
| 01/17/2008 | WO2008007836A1 Method for preparing 4-acetoxyazetidinone and derivatives thereof |
| 01/17/2008 | WO2005066120A3 Process for asymmetric synthesis of hydroxy-alkyl substituted azetidinone derivatives |
| 01/17/2008 | US20080015352 zinc complexed with triiodothyronine; improved potency, stability, absorbability, targeted delivery |
| 01/17/2008 | US20080015256 Tetralin and indane derivatives and uses thereof |
| 01/16/2008 | EP1877373A2 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/16/2008 | EP1877050A1 Substituted beta-lactams and their use in medicine |
| 01/16/2008 | EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands |
| 01/16/2008 | CN101107250A Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 01/16/2008 | CN100361970C Nover diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use |
| 01/10/2008 | US20080009494 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 01/08/2008 | US7317019 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/03/2008 | WO2008000131A1 α-AMINO-N-SUBSTITUTED AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF |
| 01/03/2008 | US20080004252 3-(3,4-Dichloro-phenoxy)-8-(1H-tetrazol-5-ylmethyl)-8-aza-bicyclo[3.2.1]octane; Central nervous system disorders |
| 01/02/2008 | EP1871741A2 Substituted azetidinones |
| 12/27/2007 | WO2007147771A2 Tetralin and indane derivatives and uses thereof |
| 12/27/2007 | WO2007147770A2 Substituted phenyl methanone derivatives |
| 12/27/2007 | WO2007116230A8 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
| 12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/27/2007 | US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use |
| 12/27/2007 | US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers |
| 12/27/2007 | CA2653758A1 Tetralin and indane derivatives and uses thereof |
| 12/27/2007 | CA2653355A1 Substituted phenyl methanone derivatives |
| 12/26/2007 | EP1868434A2 Beta-lactamylalkanoic acids for treating premenstrual disorders |
| 12/25/2007 | US7312235 Anticoagulants |
| 12/21/2007 | WO2007144503A2 Novel process for preparing nitrones and n-hydroxylamines comprising at least one hydroxyl group, and products thus obtained |
| 12/21/2007 | CA2647902A1 Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof |
| 12/19/2007 | EP1867656A1 Compound having cyclic structure and use thereof |
| 12/19/2007 | EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions |